Armin Maier
Impact in
- Biotechnology top 0.5%
- Marine Sponges and Natural Products
- Pharmacology top 0.5%
- Microbial Natural Products and Biosynthesis
- Fungal Biology and Applications
Papers in
- Pharmacology 33
- Microbial Natural Products and Biosynthesis 33
- Fungal Biology and Applications 5
-
- Cancer therapeutics and mechanisms 5
- Phytochemical compounds biological activities 4
- Co-authors
- Heinz‐Herbert Fiebig (29 shared papers)Christian Hertweck (12 shared papers)Ling Ding (10 shared papers)Wenhan Lin (8 shared papers)Gerhard Kelter (19 shared papers)Stefan Kehraus (8 shared papers)Gabriele M. König (6 shared papers)Heinz H. Fiebig (13 shared papers)
- Journals
- Journal of Natural Products (10 papers)Cancer Research (7 papers)The Journal of Antibiotics (7 papers)Molecular Cancer Therapeutics (4 papers)European Journal of Organic Chemistry (3 papers)
- Partner nations
- GermanyChinaSwitzerland
In The Last Decade
Armin Maier
55 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 88
- Biotechnology 641
- Pharmacology 1.0k
- Toxicology 122
- Organic Chemistry 555
- Pharmacology 118
Countries citing papers authored by Armin Maier
This map shows the geographic impact of Armin Maier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Armin Maier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Armin Maier more than expected).
Fields of papers citing papers by Armin Maier
This network shows the impact of papers produced by Armin Maier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Armin Maier. The network helps show where Armin Maier may publish in the future.
Co-authors
The 25 scholars most cited alongside Armin Maier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 202 | |
| 2 | 2011 | 166 | |
| 3 | 2007 | 99 | |
| 4 | 2005 | 97 | |
| 5 | 2009 | 96 | |
| 6 | 2011 | 94 | |
| 7 | 2009 | 81 | |
| 8 | 2013 | 69 | |
| 9 | 2007 | 67 | |
| 10 | 2011 | 67 | |
| 11 | 2008 | 60 | |
| 12 | 2010 | 57 | |
| 13 | 2012 | 55 | |
| 14 | 2014 | 40 | |
| 15 | 2015 | 39 | |
| 16 | 2012 | 39 | |
| 17 | 2011 | 34 | |
| 18 | 2007 | 34 | |
| 19 | 2008 | 34 | |
| 20 | 2015 | 30 |
About Armin Maier
Armin Maier is a scholar working on Pharmacology, Molecular Biology, Biotechnology, Cancer Research and Organic Chemistry, having authored 60 papers that have together received 1.9k indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (33 papers), Marine Sponges and Natural Products (23 papers), Synthesis and Biological Activity (11 papers), Bioactive Compounds and Antitumor Agents (7 papers), Synthetic Organic Chemistry Methods (7 papers), Fungal Biology and Applications (5 papers), Cancer therapeutics and mechanisms (5 papers) and Phytochemical compounds biological activities (4 papers). The work is most often cited by research in Biotechnology (641 citations), Pharmacology (1.0k citations), Toxicology (122 citations), Organic Chemistry (555 citations) and Pharmacology (118 citations). Armin Maier has collaborated with scholars based in Germany, China and Switzerland. Frequent co-authors include Heinz‐Herbert Fiebig, Christian Hertweck, Ling Ding, Wenhan Lin, Gerhard Kelter, Stefan Kehraus, Gabriele M. König, Heinz H. Fiebig, Helmar Goerls and Hartmut Laatsch. Their work appears in journals such as Journal of Natural Products, Cancer Research, The Journal of Antibiotics, Molecular Cancer Therapeutics and European Journal of Organic Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.